Overview
- 21 inspections across 21 sites are on record.
- 25 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-02-05.
At a glance
Inspections
21
Sites
21
Observations
25
Career since
Sep 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Grifols Therapeutics LLC | 5 Feb 2026 | Biologics | On file |
| AbbVie Bioresearch Center | 16 Dec 2025 | Biologics | On file |
| Dendreon Pharmaceuticals LLC | 29 Oct 2025 | Biologics | On file |
| Quality Chemical Laboratories | 24 Jul 2025 | Biologics | |
| Eurofins BioPharma Product Testing Spain SLU | 19 Jun 2025 | Biologics |
Sites inspected
Grifols Therapeutics LLCClayton, United States1 insp.
AbbVie Bioresearch CenterWorcester, United States1 insp.
Dendreon Pharmaceuticals LLCUnion City, United States1 insp.
Quality Chemical LaboratoriesWilmington, United States1 insp.
Eurofins BioPharma Product Testing Spain SLUEsplugues De Llobregat, Spain1 insp.
Co-investigators
Investigators who share inspections with this person.
Brentley S Collins8 shared
Alan L Truong5 shared
Gene D Arcy3 shared
Laurel A Beer2 shared
Priscilla M Pastrana2 shared
Anissa M Cheung2 shared
Katarzyna I Jankowska1 shared
Jennifer L Reed1 shared
Vijaya L Simhadri1 shared
Richard L Bartlett1 shared
Full investigator report
Get the verbatim findings behind Brentley S Pittman's 25 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site